Bio-Vascular raises $26 million
This article was originally published in Clinica
Bio-Vascular, a US surgery and imaging software company based in Minnesota, has raised around $26 million net in a share offer last week. The size of the offer was increased to 1.8 million from 1.5 million shares and the price achieved was some 10% above the assumed price in the prospectus. The shares were sold for $15.75. Bio-Vascular now intends to transfer its shares from the Nasdaq smallcap market to the Nasdaq proper.